Loratadine Tablets Recalled for Potential Labeling Mixup
Aidapak Services is recalling Loratadine 10 mg tablets because they may be mislabeled as Glycopyrrolate or Omega-3 fatty acids.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported injuries or illnesses, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling Loratadine Tablet, 10 mg, Rx only, NDC 45802065078. The recall is due to a labeling mixup where the product may be mislabeled as Glycopyrrolate Tablet, 2 mg, or Omega-3 Fatty Acid Capsule, 1000 mg.
The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington. The recall involves 799 tablets with specific pedigree and expiration codes listed in the agency notice.
Consumers should check their medication for the NDC 45802065078 and contact their pharmacist or healthcare provider for instructions on how to proceed.
The recalled product
- Product
- LORATADINE Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 45802065078
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 799
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- LORATADINE
- Tablet
- 10 mg has the following codes Pedigree: W002652
- EXP: 6/5/2014
- Pedigree: AD22865_7
- EXP: 5/2/2014
- Pedigree: W003253
- EXP: 6/17/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateFDA Recalls Levothyroxine Sodium Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Glycopyrrolate Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Lovastatin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Multivitamin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Modafinil Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Lorazepam Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29